Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
MA02 - Improving Outcomes for Patients with Lung Cancer
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 12
- Coordinates: 9/24/2018, 10:30 - 12:00, Room 201 BD
-
+
MA02.01 - ROS1 Gene Rearrangements Are Associated with an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events
10:30 - 10:35 | Presenter: Terry L. Ng
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MS01 - Cancer Pathways, Targeted Therapy and Resistance
- Type: Mini Symposium
- Track: Biology
- Presentations: 5
- Coordinates: 9/24/2018, 10:30 - 12:00, Room 206 F
-
+
MS01.04 - Addressing Drug Resistance Beyond Kinase Domain Mutations
11:30 - 11:50 | Presenter: Robert C. Doebele
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- Type: Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 8
- Coordinates: 9/24/2018, 10:30 - 12:00, Room 105
-
+
OA02.01 - Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
10:30 - 10:40 | Presenter: Robert C. Doebele
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA02.02 - Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
10:40 - 10:50 | Presenter: Jessica Jiyeong Lin
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA04 - Novel Approaches with IO
- Type: Mini Oral Abstract Session
- Track: Immunooncology
- Presentations: 12
- Coordinates: 9/24/2018, 13:30 - 15:00, Room 107
-
+
MA04.09 - Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)
14:30 - 14:35 | Presenter: Valerie W Rusch
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 112
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.01-78 - The Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib
16:45 - 18:00 | Presenter: Tejas Patil
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 45
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.13-36 - Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Lecia Sequist
- Abstract
Loading... -
+
P1.13-44 - Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
16:45 - 18:00 | Presenter: Joel W. Neal
- Abstract
Loading...
-
+
OA10 - Right Patient, Right Target & Right Drug - Novel Treatments and Research Partnerships
- Type: Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 8
- Coordinates: 9/25/2018, 10:30 - 12:00, Room 106
-
+
OA10.02 - Oncogene-Driven Patient Groups: A New Era For Research Partnerships
10:40 - 10:50 | Presenter: Janet Freeman-Daily
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA16 - Novel Mechanisms for Molecular Profiling
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 12
- Coordinates: 9/25/2018, 13:30 - 15:00, Room 203 BD
-
+
MA16.11 - Discussant - MA 16.08, MA 16.09, MA 16.10
14:40 - 14:55 | Presenter: Robert C. Doebele
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA12 - Novel Therapies in MET, RET and BRAF
- Type: Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 8
- Coordinates: 9/25/2018, 15:15 - 16:45, Room 106
-
+
OA12.06 - Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure
16:10 - 16:20 | Presenter: Anastasios Dimou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.